CNO Financial Group, Inc. (CNO) Stock Analysis

Q: What is the CNO stock price target?

Entry $40.77, take-profit $44.04 (+8.0% upside). Target $44.04 (-1.2%), stop $39.16 (−13.8%), A.R:R -1.3:1.

HoldModerate ConfidenceUpdated 2026-04-30

Financial Services · Insurance - Life

Earnings in 0 days (2026-04-30). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

CNO Financial Group develops and markets health insurance, annuities, and life insurance for middle-income pre-retiree and retired Americans under Bankers Life, Washington National, and Colonial Penn brands. Generated $4.5B revenue and held $38.8B total assets in 2025,... Read more

$44.56+8.0% A.UpsideScore 5.8/10#6 of 15 Insurance - Life

Entry $40.77(support + ATR)Stop $39.16Target $44.04(resistance)A.R:R -1.3:1Setup A.R:R 2.0:1

Analyst target$46.00+3.2%4 analysts

$44.04our TP

$44.56price

$46.00mean

$43

$51

Hold if already holding. Not a fresh buy at $44.56, but acceptable to hold if already in. Reasons: Concentration risk — Counterparty: seven largest reinsurers (99.0%); Analyst target reached - limited upside remaining. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Downgraded from BUY WAIT — price $44.39 has reached target $44.04. No upside to wait for. Score 5.8/10, moderate confidence.

Passes 4/6 gates (positive momentum, clean insider activity, no SEC red flags, semi cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 0d<=7d. Suitability: aggressive.

Thesis

Rewards

No bull case signals

Risks

Concentration risk — Counterparty: seven largest reinsurers (99.0%)

Analyst target reached - limited upside remaining

Near 52-week high (1.2% away)

Key Metrics

P/E (TTM)19.4

P/E (Fwd)9.1

Mkt Cap$4.2B

EV/EBITDA7.5

Profit Mgn5.1%

ROE8.9%

Rev Growth4.2%

Beta0.84

Dividend1.52%

Rating analysts10

Quality Signals

Piotroski F8/9

Options Flow

P/C0.67bullish

IV56%elevated

Max Pain$35-21.5% vs spot

Concentration Risks(10-K Item 1A)

HIGHcounterpartyseven largest reinsurers99%
10-K Item 1A: 'Our seven largest reinsurers, which are rated "A-" or higher by AM Best as of December 31, 2025, accounted for 97 percent of our ceded life insurance inforce and 99 percent of our reinsurance receivables.'

Material Events(8-K, last 90d)

2026-02-11Item 5.02LOW
Director Mary R. (Nina) Henderson informed Board she will retire at the 2026 annual meeting. Not based on any disagreement with the Company on any matter.
SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

10 dimensions · all in-band

Overall = weighted sum of the 10 dimension scores. Fundamentals (Value/Quality/Growth) carry 45%; market signals (Momentum/Sentiment/Insider/Peer) carry 40%; structure (Technical/Risk/Catalyst) carries 15%.

DimensionScoreWeightContribution

Value7.615%1.14

Quality5.415%0.81

Growth6.815%1.02

Momentum6.410%0.64

Sentiment5.210%0.52

Insider Activity3.310%0.33

Peer Rank4.010%0.40

Technical Setup4.85%0.24

Risk Profile7.05%0.35

Catalyst8.05%0.40

Overall (Σ contributions)5.85

Small float-rounding may cause last-digit differences between this sum and the displayed Overall.

GatesA.R:R -1.3=NEGATIVEEARNINGS PROXIMITY 0d<=7dMomentum 6.4>=5.5Insider activity: OKNo SEC red flagsSEMI CYCLE PEAK CLEARSuitability: Aggressive

RSI

76 · Overbought

↑ 20D MA↑ 50D MA↑ 200D MAGOLDEN CROSSSupport $40.37Resistance $44.94

Price Targets

$39

$41

$44

A.Upside-1.2%

A.R:R-1.3:1

Setup A.R:R (at entry)2.0:1

Position Sizing

ConvictionNone

Suggested %0.5%

Max %1%

RegimeSteady

Risk Alerts

! Target reached (-11.9% upside)

! Earnings in 0 days - binary event risk

! Negative risk/reward — downside exceeds upside

Earnings

3/4 beats

Next Earnings2026-04-30 (0d)

Verdict History

reverse chrono — latest first

Loading history...

Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.

Frequently Asked Questions

Is CNO stock a buy right now?

Hold if already holding. Not a fresh buy at $44.56, but acceptable to hold if already in. Reasons: Concentration risk — Counterparty: seven largest reinsurers (99.0%); Analyst target reached - limited upside remaining. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Downgraded from BUY WAIT — price $44.39 has reached target $44.04. No upside to wait for. Target $44.04 (-1.2%), stop $39.16 (−13.8%), A.R:R -1.3:1. Score 5.8/10, moderate confidence.

What is the CNO stock price target?

Take-profit target: $44.04 (+8.0% upside). Target $44.04 (-1.2%), stop $39.16 (−13.8%), A.R:R -1.3:1. Stop-loss: $39.16.

What are the risks of investing in CNO?

Concentration risk — Counterparty: seven largest reinsurers (99.0%); Analyst target reached - limited upside remaining; Near 52-week high (1.2% away).

Is CNO overvalued or undervalued?

CNO Financial Group, Inc. trades at a P/E of 19.4 (forward 9.1). TrendMatrix value score: 7.6/10. Verdict: Hold.

What do analysts say about CNO?

10 analysts cover CNO with a consensus score of 3.6/5. Average price target: $46.

What does CNO Financial Group, Inc. do?CNO Financial Group develops and markets health insurance, annuities, and life insurance for middle-income pre-retiree...